COMMUNIQUÉS West-GlobeNewswire

Beech Acres Parenting Center Wins Seven National Top Workplaces Awards, Including Nonprofit Industry and Culture Excellence Awards
09/04/2026
CINCINNATI, April 09, 2026 (GLOBE NEWSWIRE) -- Beech Acres Parenting Center, where highly engaged and supported staff inspire and equip today’s parents, families and communities to raise capable, resilient and [...]
Cerevance to Present Positive Phase 2 Solengepras Data in Parkinson’s Disease at the American Academy of Neurology 2026 Annual Meeting
09/04/2026
Solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor, demonstrated meaningful reductions in daily OFF time and improvements in sleep-related symptoms across two Phase 2 trials Meeting presentations highlight [...]
Alignment Healthcare to Announce First Quarter 2026 Financial Results and Host Conference Call Thursday, April 30, 2026
09/04/2026
ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release [...]
MMI Introduces World’s First Microsurgical Suture for Robotics
09/04/2026
New suture expands the Symani ecosystem, supporting greater efficiency and precision in robotic microsurgery JACKSONVILLE, Fla., April 09, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics [...]
Tria Federal Earns Prestigious 2026 USA TODAY Top Workplaces Award
09/04/2026
ARLINGTON, Va., April 09, 2026 (GLOBE NEWSWIRE) -- Tria Federal is proud to announce that it has earned the prestigious 2026 USA TODAY Top Workplaces award. The award honors organizations with 150 or more employees that [...]
Imprivata Appoints Cindy Zhou as Chief Marketing Officer
09/04/2026
Award-winning cybersecurity marketing executive brings extensive experience in leading high-impact teams to elevate Imprivata’s global market leadership WALTHAM, Mass., April 09, 2026 (GLOBE NEWSWIRE) -- Imprivata , a [...]
Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members
09/04/2026
New integration delivers on Noom's pledge to the CMS Health Technology Ecosystem initiative to enable deeper personalization within Noom’s diabetes and obesity programs PRINCETON, N.J., April 09, 2026 (GLOBE NEWSWIRE [...]
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
09/04/2026
MALVERN, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
Sonablate Expands Leadership to Accelerate Growth in Incision-Free Prostate Care Solutions
09/04/2026
Appointments support rising demand for HIFU and advance the “precision sound medicine” platform across new clinical applications CHARLOTTE, N.C., April 09, 2026 (GLOBE NEWSWIRE) -- Sonablate , a global leader in focused [...]
The Science Behind Glycocalyx Support: Why Rhamnan Sulfate Is Different
09/04/2026
Rhamnan sulfate is a marine-derived polysaccharide specifically studied for its structural affinity to the endothelial glycocalyx, the lining inside every blood vessel. Calroy holds patents on microfluidic chip [...]
Soleo Health Opens New Ambulatory Infusion Center in Austin, Texas
09/04/2026
FRISCO, Texas and AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of its new ambulatory [...]
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
09/04/2026
TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of [...]
Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours
09/04/2026
Collaboration leverages OBT's proprietary OGAP®-Verify discovery platform and drug development capabilities in alignment with BMS’s expertise to advance selected novel oncology targets This is OBT’s third major pharma [...]
Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference
09/04/2026
TORONTO, April 09, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“ Satellos ” or the “ Company ”), a clinical-stage biotechnology company developing life-improving medicines to treat [...]
Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155
09/04/2026
The financing combines a $50M Series D investment by Boehringer Ingelheim with additional dedicated funding to support commercialization. As part of the agreement, Boehringer is transferring responsibility for [...]
Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
09/04/2026
New preclinical data for FHD-909 (LY4050784) reinforcing the potential for expansion opportunities in combination with an anti-PD-1 antibody in SMARCA4 (BRG1)-mutant lung cancer Preclinical characterization of FHT-171, [...]
Nkarta to Participate in Needham Virtual Healthcare Conference
09/04/2026
SOUTH SAN FRANCISCO, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune [...]
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
09/04/2026
• Adam Schayowitz, Ph.D., MBA appointed as Head of R&D • Scott Platshon appointed as Chief Business Officer VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a [...]
C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)
09/04/2026
Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Third Target C4T to Develop Degraders With Payload Properties; Roche to Conjugate Payloads to Targeted Antibodies C4T to [...]

Pages